InsidersTradesSigma
PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025: management transactions · Italy · Consob
CONSOB:pharmanutra-pharmanutra-spa-cda-approva-il-resoconto-intermedio-di-gestione-al-3-f4e316IT·ConsobHealth Care
Browse the full directors' dealings record of PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025, a listed issuer based in Italy. Shares trade on IT IT, under the oversight of Consob. Operating in the Health Care sector, PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025 has logged 0 public disclosures. Every trade is accessible without an account.
0
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Declarations0 total
No declarations found
0 of 0 declarations